155 related articles for article (PubMed ID: 10606292)
1. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: is it worth the cost?
Brand RE
Am J Gastroenterol; 1999 Dec; 94(12):3404. PubMed ID: 10606292
[No Abstract] [Full Text] [Related]
2. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
[TBL] [Abstract][Full Text] [Related]
3. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis.
Bass NM
N Engl J Med; 1999 Aug; 341(6):443-4. PubMed ID: 10432331
[No Abstract] [Full Text] [Related]
4. [Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis].
Grange JD; Amiot X
Gastroenterol Clin Biol; 2000 Mar; 24(3):378-9. PubMed ID: 10866518
[No Abstract] [Full Text] [Related]
5. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis.
Patch D; Burroughs A
N Engl J Med; 1999 Dec; 341(23):1773-4. PubMed ID: 10610455
[No Abstract] [Full Text] [Related]
6. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
7. Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Cartier M; Terg R; Lucero R; Muñoz A; Romero G; Levi D; Miguez C; Abecasis R
Aliment Pharmacol Ther; 2010 Jul; 32(1):43-8. PubMed ID: 20345510
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
[TBL] [Abstract][Full Text] [Related]
9. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
[TBL] [Abstract][Full Text] [Related]
10. Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis.
Ensaroğlu F; Korkmaz M; Geçkil AÜ; Öcal S; Koç B; Yıldız Ö; Atalay FB; Taş EG; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():131-6. PubMed ID: 26640933
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998.
Thuluvath PJ; Morss S; Thompson R
Am J Gastroenterol; 2001 Apr; 96(4):1232-6. PubMed ID: 11316175
[TBL] [Abstract][Full Text] [Related]
12. Albumin infusion in liver cirrhotic patients.
Rena NM; Wibawa ID
Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.
Jepsen P; Vilstrup H; Møller JK; Sørensen HT
Hepatogastroenterology; 2003; 50(54):2133-6. PubMed ID: 14696480
[TBL] [Abstract][Full Text] [Related]
14. Albumin infusion for spontaneous bacterial peritonitis.
Runyon BA
Lancet; 1999 Nov; 354(9193):1838-9. PubMed ID: 10584717
[No Abstract] [Full Text] [Related]
15. Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
Taşkiran B; Colakoğlu O; Sözmen B; Unsal B; Aslan SL; Buyraç Z
Turk J Gastroenterol; 2004 Mar; 15(1):34-8. PubMed ID: 15264119
[TBL] [Abstract][Full Text] [Related]
16. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
Tuncer I; Topcu N; Durmus A; Turkdogan MK
Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
[TBL] [Abstract][Full Text] [Related]
18. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Fernández J; Monteagudo J; Bargallo X; Jiménez W; Bosch J; Arroyo V; Navasa M
Hepatology; 2005 Sep; 42(3):627-34. PubMed ID: 16108036
[TBL] [Abstract][Full Text] [Related]
19. Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?
Wong F
Hepatology; 2005 Sep; 42(3):533-5. PubMed ID: 16116626
[No Abstract] [Full Text] [Related]
20. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
